Medical Science Liaisons in Real-World Evidence Studies: Experience of AstraZeneca Russia

Suvorov, Nikolay; Karaseva, V.; Stukalina, Ekaterina; Sanay, Elkhan; Petrakovskaya, Vera; Bulatov, Vladimir

doi:10.1177/2168479017717571

Cited by 5 publications

(4 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is not a confirmed response about why it happened, but we are wondering if HCPs/KOL are really aware about this capability from the MSLs. Although we know that it is not easy to support the research, there are multiple examples of how MSLs have contributed to enhance different investigator initiated trials (ITT) [ 16 ]. Furthermore, it was interesting to find that HCPs/KOL stated that the time they dedicated to the MSLs was less than 10 min.…”

Section: Discussionmentioning

confidence: 99%

The Medical Science Liaison Role in Spain: A Survey About the Opinion of HealthCare Professionals

Castillo

García²,

Matesanz-Marín³

et al. 2021

Ther Innov Regul Sci

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

The Medical Science Liaison Role in Spain: A Survey About the Opinion of HealthCare Professionals

Castillo

García²,

Matesanz-Marín³

et al. 2021

Ther Innov Regul Sci

View full text Add to dashboard Cite

“…Sometimes, the MSLs have an important contribution on this research by improving the recruitment based on their visits where they exchange scientific discussions about the study. [ 4 ]…”

Section: Introductionmentioning

confidence: 99%

The medical science liaison role in Spain

Sastre

Matesanz-Marín

García

et al. 2022

Perspectives in Clinical Research

View full text Add to dashboard Cite

Context and Aims: The Medical Science Liaison's (MSL's) value to the company has evolved into a more strategic role with a wide variety of responsibilities. We conducted an online survey of current MSLs nationwide to assess their profile, activity development, performance evaluation, and career development. Subjects and Methods: A 37-item survey was hosted on SurveyMonkey© and accessible from December 2018 to February 2019. The survey was open to current MSLs from different pharmaceutical companies in Spain and included questions about the participant profile, activity development, performance evaluation, and career development. Statistical Analysis Used: The results were expressed as valid percentages; to establish relationships between the answers to different questions, exclusion and comparison filters were used on the web platform. Results: A total of 179 MSLs responded to the anonymous survey. Off-label information management (79%), relationships with key opinion leaders (76%), continuous medical training for HCPs (70%), involvement in clinical trials/investigator-initiated trials (68%), and elaboration of the National Strategy (67%) were mentioned as the top new competencies. Fifty-eight percent spend an average of 61%–80% of their time out in the field and 68% use remote interactions. Fifty-six percent did not agree that their current performance metrics are a reflection of their true value. Forty-five percent of the participants disagreed when asked if their activity is easily balanced with their personal lives. Conclusions: Based on our findings, we believe that there is a need to consider the MSL's strategic priorities, to define metrics that accurately assess MSL performance, and to find ways to fully maximize their limited time.

show abstract

“…In Europe, the MSL functions became independent of sales departments in response to such developments in the United States, and MA departments have become important in Europe and America. MSL functions are also present in Asia ( 9 ), Russia ( 10 ), and Africa ( 11 ), becoming popular functions in pharmaceutical companies.…”

Section: History Of Mamentioning

confidence: 99%

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan

Maeda

2021

Front. Med.

View full text Add to dashboard Cite

Medical affairs has received a lot of attention in recent years in Japan, but it is also often misunderstood or poorly understood in the healthcare industry in Japan. In the United States, the function of medical affairs has been established for a long time, whereas its history in Japan is relatively short. Many scandals in clinical trials occurred with inappropriate relationship between medical doctors and the sales departments of pharmaceutical companies from 2012. These incidents undermined confidence in clinical trials in Japan and triggered the enforced separation of sales departments from the conduct of post-marketing clinical trials and evidence generation. There have been growing compliance issues identified in marketing and sales practices, and off-label promotion is also becoming an issue in Japan. These issues resulted in the establishment of independent medical affairs departments from sales departments in pharmaceutical companies operating in Japan. Due to the short history of medical affairs in Japan, the roles and responsibilities vary between companies in Japan. Medical affairs departments aim to fulfill unmet medical needs through the generation of scientific evidence and to deliver scientific value to key stakeholders and patients. People working in medical affairs need to engage in scientific exchange activities with key opinion leaders independent of sales departments. Through these activities, medical affairs ensures that patients receive optimal medical care. Medical affairs in Japan is still developing, and its roles, responsibilities, and functions are improving. This article covers the history of medical affairs in Japan and the current status and future perspectives of medical affairs in Japan.

show abstract

Medical Science Liaisons in Real-World Evidence Studies: Experience of AstraZeneca Russia

Cited by 5 publications

References 5 publications

The Medical Science Liaison Role in Spain: A Survey About the Opinion of HealthCare Professionals

The Medical Science Liaison Role in Spain: A Survey About the Opinion of HealthCare Professionals

The medical science liaison role in Spain

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan

Contact Info

Product

Resources

About